CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult drug associated with AE in senior drug associated with AE in pediatric used to treat disease Topoisomerase Inhibitors [MoA] Bronchitis [Disease/Finding] Chlamydia Infections [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Escherichia coli Infections [Disease/Finding] Haemophilus Infections [Disease/Finding] Klebsiella Infections [Disease/Finding] Legionnaires' Disease [Disease/Finding] Mycoplasma Infections [Disease/Finding] Proteus Infections [Disease/Finding] Pseudomonas Infections [Disease/Finding] Pyelonephritis [Disease/Finding] Salmonella Infections [Disease/Finding] Staphylococcal Infections [Disease/Finding] Streptococcal Infections [Disease/Finding] Tuberculosis, Pulmonary [Disease/Finding] Urinary Tract Infections [Disease/Finding] Maxillary Sinusitis [Disease/Finding] Eye Infections, Bacterial [Disease/Finding] Skin Diseases, Bacterial [Disease/Finding] Pneumonia, Bacterial [Disease/Finding] Soft Tissue Infections [Disease/Finding] Decreased DNA Integrity [PE] Decreased Protein Synthesis [PE] Increased Protein Breakdown [PE] L [Preparations] LEVOFLOXACIN http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020634s062s064,020635s068s070,021721s029s031lbl.pdf C0282386 82122 Levofloxacin N0000148474 Ingredient LEVOFLOXACIN C16454 <VANDF_Record>50.6^3386^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3386</VA_IEN> 4021005 Active 6GNT3Y5LMF <VANDF_Record>50.416^3672^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3672</VA_IEN> Levofloxacin [Chemical/Ingredient] pneumonia headache AE dizziness AE nausea AE vomiting AE constipation AE diarrhea AE insomnia AE